JPH04149113A - Whitening cosmetic - Google Patents
Whitening cosmeticInfo
- Publication number
- JPH04149113A JPH04149113A JP27132990A JP27132990A JPH04149113A JP H04149113 A JPH04149113 A JP H04149113A JP 27132990 A JP27132990 A JP 27132990A JP 27132990 A JP27132990 A JP 27132990A JP H04149113 A JPH04149113 A JP H04149113A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- ascorbic acid
- whitening
- dicarboxylic acid
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 28
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 239000000126 substance Substances 0.000 claims abstract 6
- 101100167062 Caenorhabditis elegans chch-3 gene Proteins 0.000 claims 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 21
- 230000015572 biosynthetic process Effects 0.000 abstract description 10
- 238000011084 recovery Methods 0.000 abstract description 8
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 239000000839 emulsion Substances 0.000 abstract description 4
- 239000006071 cream Substances 0.000 abstract description 3
- 239000006210 lotion Substances 0.000 abstract description 3
- 239000000843 powder Substances 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 abstract description 2
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 239000000049 pigment Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 26
- 238000012360 testing method Methods 0.000 description 19
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 11
- 229960005070 ascorbic acid Drugs 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 150000000996 L-ascorbic acids Chemical class 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000011668 ascorbic acid Substances 0.000 description 9
- 235000010323 ascorbic acid Nutrition 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 235000010384 tocopherol Nutrition 0.000 description 5
- 229930003799 tocopherol Natural products 0.000 description 5
- 239000011732 tocopherol Substances 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- -1 tocopherol phosphate ester Chemical class 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010014970 Ephelides Diseases 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 206010042496 Sunburn Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000001384 succinic acid Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 2
- XJMMNTGIMDZPMU-UHFFFAOYSA-N 3-methylglutaric acid Chemical compound OC(=O)CC(C)CC(O)=O XJMMNTGIMDZPMU-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- CGFPNELNAZZYQL-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfuric acid Chemical compound OS(O)(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CGFPNELNAZZYQL-RXSVEWSESA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- IDRUFHLMTBZQBT-NSCUHMNNSA-N 2-[(e)-prop-1-enyl]propanedioic acid Chemical compound C\C=C\C(C(O)=O)C(O)=O IDRUFHLMTBZQBT-NSCUHMNNSA-N 0.000 description 1
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- QEVGZEDELICMKH-UHFFFAOYSA-N Diglycolic acid Chemical compound OC(=O)COCC(O)=O QEVGZEDELICMKH-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- TVIDDXQYHWJXFK-UHFFFAOYSA-N dodecanedioic acid Chemical compound OC(=O)CCCCCCCCCCC(O)=O TVIDDXQYHWJXFK-UHFFFAOYSA-N 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- MAZWDMBCPDUFDJ-UHFFFAOYSA-N trans-Traumatinsaeure Natural products OC(=O)CCCCCCCCC=CC(O)=O MAZWDMBCPDUFDJ-UHFFFAOYSA-N 0.000 description 1
- MAZWDMBCPDUFDJ-VQHVLOKHSA-N traumatic acid Chemical compound OC(=O)CCCCCCCC\C=C\C(O)=O MAZWDMBCPDUFDJ-VQHVLOKHSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は新規な美白化粧料に関する。さらに詳しくは、
ビタミンC−E誘導体を含有することを中
特徴とする、美白効果文保存安定性に優れた美白化粧料
に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a novel whitening cosmetic. For more details,
This invention relates to a whitening cosmetic with excellent whitening effect and storage stability, which is characterized by containing a vitamin C-E derivative.
−Cにシミ、ソバカス、日焼けなどに見られる皮膚の色
素沈着は、皮膚内に存在するチロシンがチロシナーゼの
作用により酸化されてメラニンとなり、このメラニンが
過剰に生成することに基因するとされている。-C Skin pigmentation seen in spots, freckles, sunburn, etc. is said to be caused by tyrosine present in the skin being oxidized to melanin by the action of tyrosinase, and this melanin being produced in excess.
従来より、この色素沈着の予防或いは治療を目的として
、アスコルビン酸が使用されている。Conventionally, ascorbic acid has been used for the purpose of preventing or treating pigmentation.
しかし、アスコルビン酸は、熱や光に対して極めて不安
定で、酸化され易く、特に水系の化粧料中においては、
分解して変臭、着色を招く原因となる。However, ascorbic acid is extremely unstable to heat and light and easily oxidized, especially in water-based cosmetics.
It decomposes and causes odor and discoloration.
これらの問題点を解決する為、アスコルビン酸に級脂肪
酸エステル、アスコルビン酸硫酸エステル、L−アスコ
ルビン酸りん酸マグ不ソウム、トコフェロール−し一ア
スコルビンM −2’、) ン酸エステル、トコフェロ
ール−L−アスコルビン酸6−ジカルボン酸ジエステル
等の各種のアスコルビン酸誘導体が使用されている。In order to solve these problems, ascorbic acid esters, ascorbic acid sulfate, L-ascorbic acid phosphate, tocopherol phosphate ester, tocopherol L- Various ascorbic acid derivatives such as ascorbic acid 6-dicarboxylic acid diester are used.
しかし、アスコルビン酸高級脂肪酸エステルは、安定性
は改善されているものの、美白効果が弱い。However, although ascorbic acid higher fatty acid ester has improved stability, it has a weak whitening effect.
アスコルビン酸硫酸エステルは、水溶性である為、油系
の化粧料に配合しづらく、美白効果も弱い。Because ascorbic acid sulfate is water-soluble, it is difficult to incorporate into oil-based cosmetics and has a weak whitening effect.
L−アスコルビン酸りん酸マグ不ノウムは、美白効果に
は優れているが、皮膚透過性が不十分であるため、美白
効果を得る為には、配合料を多く巳なければならない。L-ascorbic acid phosphate magnonium has an excellent whitening effect, but its skin permeability is insufficient, so in order to obtain a whitening effect, a large amount of ingredients must be added.
トコフェロール−し−アスコルビン酸−2−りん酸エス
テルの塩は、塩の種類によっては水に不溶のものがある
為、処方を組みにくい。Tocopherol-shi-ascorbic acid-2-phosphate salts are difficult to formulate because some salts are insoluble in water depending on the type of salt.
上記の欠点を克服するものとして、トコフェロール−し
−アスコルビン酸−6−ジカルボン酸ジエステルが1−
17されている(特開昭62=] 87470)。しか
しこの化合物はビタミンCの油溶性が高められており、
高い美白効果を有しているものの、保存によって分解し
易く、活性の低下が著しいという問題点がある。To overcome the above-mentioned drawbacks, tocopherol-shi-ascorbic acid-6-dicarboxylic acid diester 1-
17 (Japanese Unexamined Patent Application Publication No. 1983-87470). However, this compound has increased oil solubility of vitamin C,
Although it has a high whitening effect, it has the problem that it easily decomposes upon storage and its activity decreases significantly.
従って本発明の目的は、美白効果に優れ、ビタミンCの
溶解性が改善されており、しかもビタミンCの保存安定
性に優れた、美白化粧料を提供することにある。Therefore, an object of the present invention is to provide a whitening cosmetic that has excellent whitening effects, improved solubility of vitamin C, and excellent storage stability of vitamin C.
本発明は、
ill 下記一般式(1)又は(It)で表されるト
コフェロール−し−アスコルビン酸−ジカルボン酸ジエ
ステルを含有することを特徴とする美白化粧料。The present invention is directed to a whitening cosmetic containing a tocopherol-ascorbic acid-dicarboxylic acid diester represented by the following general formula (1) or (It).
(式 %式%() かを意味し、。(formula %formula%() It means,.
は
0の整数、
r、s、t、u、vはO〜4の整数を表し、R6R3は
、H又はCH,を表す。)
(2) 下記一般式(In)又は(rV)で表される
トコフェロール−5,6−0−イソプロピリデン−し−
アスコルビン酸−ジカルボン酸ジエステルを含有するこ
とを特徴とする美白化粧料。represents an integer of 0, r, s, t, u, v represent an integer of 0 to 4, and R6R3 represents H or CH. ) (2) Tocopherol-5,6-0-isopropylidene represented by the following general formula (In) or (rV)
A whitening cosmetic characterized by containing an ascorbic acid-dicarboxylic acid diester.
(但し、R,、R,は、(])
しである。)
(II)
の場合と同
れるアスコルビン酸誘導体を製造する為に使用されるジ
カルボン酸としては、例えばシュウ酸、マロン酸、コハ
ク酸、グルタル酸、アジピン酸、ヒ。(However, R,, R, is (]).) Dicarboxylic acids used to produce the same ascorbic acid derivative as in (II) include, for example, oxalic acid, malonic acid, and succinic acid. Acid, glutaric acid, adipic acid, acetic acid.
メリン酸1 スヘリン酸、アゼライン酸、七ノ\ンン酸
、1.9−ノナメチレンジカルボン酸、1.10デカメ
チレンジカルボン酸、1.11−ウンデカメチレンジカ
ルボン酸、1.12−ドデカメチレンツカルボン酸、1
.11−)リデカメチレンジカルボン酸、1.14−テ
トラデカメチレンジカルボン酸115−ペンタデカメチ
レンジカルボン酸、116−へキサデカメチレンジカル
ボン酸、1.17へブタデカメチレンジカルボン酸、1
.18−オククデカメチレンジカルボン酸、ジグリコー
ル酸アセトンノカルボン酸、フマル酸、マレイン酸トラ
ンス−2−ブテンジカルボン酸、トランス)・ランス−
ムコン酸、トラウマト酸、ムチン酸グルタミン酸、アス
パラギン酸、3−メチルアンビン酸、3−メチルグルタ
ル酸、2.3−ノメチJレコハク酸等が挙げられる。Melinic acid 1 Schelic acid, azelaic acid, heptanoic acid, 1.9-nonamethylene dicarboxylic acid, 1.10 decamethylene dicarboxylic acid, 1.11-undecamethylene dicarboxylic acid, 1.12-dodecamethylene dicarboxylic acid acid, 1
.. 11-) Ridecamethylene dicarboxylic acid, 1.14-tetradecamethylene dicarboxylic acid, 115-pentadecamethylene dicarboxylic acid, 116-hexadecamethylene dicarboxylic acid, 1.17-butadecamethylene dicarboxylic acid, 1
.. 18-Occudecamethylene dicarboxylic acid, diglycolic acid, acetonocarboxylic acid, fumaric acid, maleic acid, trans-2-butenedicarboxylic acid, trans)/trans-
Examples include muconic acid, traumatic acid, mucic acid, glutamic acid, aspartic acid, 3-methylambic acid, 3-methylglutaric acid, 2,3-nomethyl-Jresuccinic acid, and the like.
本発明に用いられる、一般式Cl1l)、(八)で表さ
れるトコフェロール−5,6−0−イソプロピリデン−
1,−アスコルビン酸ジカルボン酸ジエステルは、例え
ば以下の方法によって製造することができる。Tocopherol-5,6-0-isopropylidene- represented by the general formula Cl1l), (8) used in the present invention
1,-Ascorbic acid dicarboxylic acid diester can be produced, for example, by the following method.
まず、L−アスコルビン酸をアセトン溶媒中でアセチル
クロライドと反応させ、室温下で懸濁した後、冷却する
。得られた結晶を、冷やしたアセトンで洗浄し、乾燥す
ることによって、5.6−0−イソプロピリデン−L−
アスコルビン酸を調製する。First, L-ascorbic acid is reacted with acetyl chloride in an acetone solvent, suspended at room temperature, and then cooled. The obtained crystals were washed with chilled acetone and dried to give 5.6-0-isopropylidene-L-
Prepare ascorbic acid.
次に、ジカルボン酸の酸ハロゲン化物とトコフェロール
を、エーテルのような非反応性溶媒中で、適当な塩基1
例えばピリジンを加えて反応させる。The acid halide of the dicarboxylic acid and the tocopherol are then combined in a non-reactive solvent such as an ether with a suitable base.
For example, add pyridine and react.
得られたトコフェロールのジカルボン酸エステルを、5
位及び6位の水酸基を保護したアスコルビン酸と縮合反
応させる。反応は、ピリジン等の塩基触媒存在下におい
て、ジシクロへキシルカルボジイミド、塩化チオニル等
の脱水剤により行う。The obtained tocopherol dicarboxylic acid ester was
A condensation reaction is carried out with ascorbic acid in which the hydroxyl groups at position and 6 are protected. The reaction is carried out using a dehydrating agent such as dicyclohexylcarbodiimide or thionyl chloride in the presence of a base catalyst such as pyridine.
以上のようにして得られる、トコフェロール−56−0
−イソプロピリデン−L−アスコルビン酸−2−コハク
酸ジエステルの物性値を例示する。Tocopherol-56-0 obtained as above
The physical property values of -isopropylidene-L-ascorbic acid-2-succinic acid diester are illustrated.
元素分析; C,2)1..0
融点;114〜]15°C
IR;3460 2955.1751cmU■;λ、−
、211.Inm
コ C−NMR(熔 媒 D M S O−
cl 、)δ(pp際)=11゜4,11.7.12
.5.]9.5.20.0.20.422.322.4
,23.6,23.8,24.1.24.425.42
5.5.25.9,27.4.28.7.29.030
.430.932.1,33.3,36.7,36.8
37.038.9.65.0,73.9,74.、!、
74.9゜109、]、、117.4.]1B、6,1
21.8.124.9126.4,140.6,148
.8,152.0.170.1170.7.173.0
本発明に用いられる、−a式(+)、(II)で表され
る)・コツエロールーし一アスコルビン酸−ジカルボン
酸ジエステルは、上記のトコフェロール5、6−0−イ
ソプロピリデン=L−アスコルビン酸ジカルボン酸ジエ
ステルを、THF(テトラヒドロフラン)などの溶媒に
熔かし、1N塩酸等の酸を加えて撹拌し、5.6位のイ
ソプロピリデン基を脱齢することによって製造すること
ができる。Elemental analysis; C, 2) 1. .. 0 Melting point; 114~]15°C IR; 3460 2955.1751cmU■;λ, -
, 211. Inm Co C-NMR (Medium DMS O-
cl,)δ(pp)=11°4, 11.7.12
.. 5. ]9.5.20.0.20.422.322.4
,23.6,23.8,24.1.24.425.42
5.5.25.9, 27.4.28.7.29.030
.. 430.932.1, 33.3, 36.7, 36.8
37.038.9.65.0, 73.9, 74. ,! ,
74.9°109,], 117.4. ]1B,6,1
21.8.124.9126.4, 140.6, 148
.. 8,152.0.170.1170.7.173.0 The -a formula (+), (II) used in the present invention) Kotzerol-monoascorbic acid-dicarboxylic acid diester is the above-mentioned Tocopherol 5,6-0-isopropylidene=L-ascorbic acid dicarboxylic acid diester is dissolved in a solvent such as THF (tetrahydrofuran), and an acid such as 1N hydrochloric acid is added and stirred to dissolve the isopropylidene group at the 5.6-position. can be produced by deaging.
次に、一般式(+)iI])で表される化合物の、チロ
ノナーゼ活性阻害率を第1表乙こ例示する。Next, the inhibition rate of thyrononase activity of the compound represented by the general formula (+)iI) is illustrated in Table 1.
測定方法は、実施例で説明する。The measurement method will be explained in Examples.
尚、試料中の化合物(])in)の濃度は2型梁
表
本発明の美白化粧料における、一般代(1)〜(rV)
で表されるし一アスコルビン#誘導体の含有量は、該当
化粧料の総量に対して01〜10重量%(以下重量%を
wt%と略記する。)が好ましい。In addition, the concentration of the compound (]) in) in the sample is the general range (1) to (rV) in the whitening cosmetic of the present invention.
The content of the ascorbin # derivative represented by is preferably 01 to 10% by weight (hereinafter, weight% is abbreviated as wt%) based on the total amount of the cosmetic.
Q、 ] w t%未満だと所望の効果が得にくく、)
3wt%を越えても効果の大きな増加は望めない。Q. If it is less than wt%, it is difficult to obtain the desired effect.)
Even if it exceeds 3 wt%, no significant increase in effectiveness can be expected.
本発明の美白化粧料の剤型は、特に限定されるものでな
く、クリーム状、乳液状 Q −iiヨン状パウダー状
等々の通常の化粧料の剤型を適用することが出来る。The dosage form of the whitening cosmetic of the present invention is not particularly limited, and usual cosmetic dosage forms such as cream, emulsion, gelatinous powder, etc. can be applied.
他の成分として、香料、防腐剤1着色料、皮膚栄養剤な
どを、本発明の目的を達成する範囲内で適宜配合′−得
る。Other ingredients such as fragrances, preservatives, colorants, skin nutrients, etc. may be added as appropriate within the scope of achieving the object of the present invention.
[実施例: 以下、実施例にて本発明を説明する。[Example: The present invention will be explained below with reference to Examples.
実施例に記載の■保存安定性試験(チロンナーゼ活性■
害率の安定性)、■メラニン形成抑制試験■皮膚色明度
回復試験、■美白実用試験は、下記の通りに実施した。■Storage stability test (thyronase activity■
(stability of damage rate), (melanin formation inhibition test) (skin color brightness recovery test), (b) skin whitening practical test were conducted as follows.
■ 保存安定性試験
下記の方法にて、本発明の美白化粧料の、調製直後、2
0℃3ケ月保存後、45℃3ケ月保存後のチロソナーゼ
活性阻害率を測定し、保存安定性を評価した。■ Storage stability test Immediately after preparation of the whitening cosmetic of the present invention, 2
After storage for 3 months at 0°C and 3 months at 45°C, the inhibition rate of tyrosonase activity was measured to evaluate storage stability.
ハーディングーバソセイ (Harding−Pass
ay)マウスメラノーマから抽出した酵素チロシナーゼ
を使用し、その酵素活性をドーパ−クロームの475n
mの吸光度を測定するフォトメトリー法によってしらべ
た。Harding-Pass
ay) Using the enzyme tyrosinase extracted from mouse melanoma, its enzyme activity was determined by 475n of dopachrome.
This was investigated by photometry, which measures the absorbance of m.
本発明の美白化粧料(以下試料と称す。)0,9ml!
を採取し、L−チロンン溶i’ff1(0,3mg/m
n)を1mlとマノクルへイン氏の緩衝液(p H6,
8’)を)mff加え、37℃の恒温水槽中で10分間
インキユヘートした後、これにチロシナーゼ溶液(1m
g/mjりを0.1 m !!加えてよく撹拌し、37
℃に保4って10分後、4.75 n mで吸光度(D
l)を測定する。加熱失活させたチロシナーゼを用いて
同様に反応させた吸光度(D2)および、試料の代わり
に水のみを用いた対照試験品の吸光度(D3)を測定し
、次式からチロノナーゼ活性阻害率を算出する。Whitening cosmetic of the present invention (hereinafter referred to as sample) 0.9ml!
was collected and treated with L-thironne soluble i'ff1 (0.3 mg/m
n) and Manokulhan's buffer (pH 6,
After adding 8') mff and incubating for 10 minutes in a constant temperature water bath at 37°C, tyrosinase solution (1 m
g/mj 0.1 m! ! Add and stir well, 37
After 10 minutes at 4°C, the absorbance (D) was measured at 4.75 nm.
l). Measure the absorbance (D2) of a similar reaction using heat-inactivated tyrosinase and the absorbance (D3) of a control test product using only water instead of the sample, and calculate the tyrononase activity inhibition rate from the following formula. do.
チロソナーゼ活性阻害率(%)
zDt
■ メラニン形成抑制試験
Fl系黒色モルモット(雄、約8司令、平均体重350
g)の背部皮膚を刈上後、脱毛クリームにより完全除毛
し、翌日より各試ネ4を除毛部皮膚に毎日−回、4cm
2当り0.2 g 塗布し、閉塞貼布した。尚1試料に
対して動物は一群10匹使用した。Tyrosonase activity inhibition rate (%) zDt ■ Melanin formation inhibition test Fl black guinea pig (male, approximately 8 cm, average weight 350
After cutting the back skin of g), completely remove the hair with hair removal cream, and from the next day, apply each sample 4 to the skin of the hair removal area once a day for 4 cm.
0.2 g per 2 pieces was applied and an occluded patch was applied. A group of 10 animals was used for each sample.
メラニン形成抑制効果の評価は、試験開始後1ケ月後に
実施し、高速分光色彩計を用いて塗布部の明度(Yl)
と非塗布部の明度(Yo)との比の値(’l” T /
Yo )を求め、メラニン形成j抑制率とし■ 皮膚
色明度回復試験
被試験者20名の背部皮膚に試料塗布部位と非塗布部位
とを設定し、両部位にtJV−B領域の紫外線を最小紅
斑量の2倍量照射し、】週間の後、各々の皮膚の基準明
度(Vo値1〜lo′値)を測定した。引続いて塗布部
位には試料を1日1回ずつ3ケ月間連続塗布し、3.7
.13週間後の塗布部位及び非塗布部位の皮膚の回復明
度(V、・・・値v7 ・・・値)を測定して、第2表
の判定基準により、皮膚色の回復評価を実施した。The melanin formation inhibitory effect was evaluated one month after the start of the test, and the brightness (Yl) of the applied area was measured using a high-speed spectrocolorimeter.
and the brightness of the non-coated area (Yo) ('l” T /
Yo ) was determined and the melanin formation j suppression rate was determined. ■ Skin color brightness recovery test A sample application site and a non-application site were set on the back skin of 20 test subjects, and ultraviolet rays in the tJV-B region were applied to both sites to minimize erythema. After two weeks, the standard brightness (Vo value 1 to lo' value) of each skin was measured. Subsequently, the sample was continuously applied to the application site once a day for 3 months, and 3.7
.. After 13 weeks, the restored lightness (V, . . . value v7 . . . value) of the skin of the application site and the non-application site was measured, and the recovery of skin color was evaluated according to the criteria shown in Table 2.
尚、皮膚の明度(〜゛値)は高速分光色彩計で測定して
得られたマンセル値より算出した。In addition, the brightness of the skin (~゛ value) was calculated from the Munsell value obtained by measurement with a high-speed spectrocolorimeter.
被試験者20名の評価点の平均値を求め、皮膚第
表
■ 美白実用試験
シミ2 ソバカス、日焼は等を訴える被試験者各20名
の顔面に試料を朝夕1回ずつ3ケ月間連続塗布した後の
改善効果を調査した。評価はシミソバカス、日焼けが各
々改善されたと回答した被試験者の数で示した。The average value of the evaluation scores of 20 test subjects was calculated, and the sample was applied to the faces of 20 test subjects who complained of freckles, sunburn, etc. for 3 consecutive months, once in the morning and evening. The improvement effect after application was investigated. The evaluation was expressed by the number of test subjects who answered that their freckles and sunburn were improved.
実施例1〜8、比較例1〜4
(二層型ローション)
下記の組成に於いて第3表に示す通りにL−アスコルビ
ン酸誘導体の種類及び含有量を変えて、実施例、比較例
である二層型ローションを調製して諸試験を実施した。Examples 1 to 8, Comparative Examples 1 to 4 (Two-layer lotion) In the following composition, the type and content of the L-ascorbic acid derivative were changed as shown in Table 3, and in the Examples and Comparative Examples. A two-layered lotion was prepared and tested.
その結果を第3表に示した。The results are shown in Table 3.
(]) 組成
(2) 調製方法
(A)成分の内、油溶性のものは(B)成分(油相)中
に、また水溶性のものは(C)成分(水相)中に、必要
に応して加熱して均一に溶解する。(]) Composition (2) Preparation method Among the components (A), oil-soluble ones are necessary in the (B) component (oil phase), and water-soluble ones are necessary in the (C) component (aqueous phase). Heat to dissolve uniformly.
次いで、(B)成分ン容液1(C)成分溶液を均一ムこ
混合攪拌分散した後、容器に充填する。Next, the (B) component solution 1 (C) component solution is uniformly mixed, stirred and dispersed, and then filled into a container.
使用時には内容物を均一に振盪分散して使用す(31特
性
7スコルビン酸誘導体を含有しない比較例1は、チロン
ナーゼの活性を阻害しない為、メラニン形成を抑制せず
(Y、/Yo< 1 )皮膚色の明度回復効果もほとん
どなく、実用試験の結果も悪かった。When using, the contents should be uniformly shaken and dispersed (31 Characteristic 7 Comparative Example 1, which does not contain a scorbic acid derivative, does not inhibit tyronase activity and therefore does not suppress melanin formation (Y, /Yo<1) There was almost no effect on restoring the brightness of skin color, and the results of practical tests were also poor.
アスコルビン酸誘導体として、L−アスコルビン酸すン
酸マグ不ンウムを含有する比較例2は、保存安定性は良
好であるが、メラニン形成抑制効果、皮膚色明度回復効
果に乏しく、実用試験の結果も良くなかった。Comparative Example 2, which contains magunium L-ascorbic acid sulfate as an ascorbic acid derivative, has good storage stability, but has poor melanin formation inhibiting effect and skin color brightness recovery effect, and the results of practical tests are also poor. It wasn't good.
アスコルビン酸誘導体として、α−トコフェロール−L
−アスコルビン酸−6−コハク酸ノエステルを含有する
比較例3は、比較例1.2に比べてメラニン形成抑制効
果、皮膚色明度回復効果は多少アップしているものの、
保存安定性が悪く、実用試験の結果も良くなかった。As an ascorbic acid derivative, α-tocopherol-L
-Comparative Example 3 containing ascorbic acid-6-succinic acid noester has somewhat improved melanin formation suppressing effect and skin color brightness recovery effect compared to Comparative Example 1.2, but
The storage stability was poor, and the results of practical tests were also poor.
アスコルビン酸誘導体としてα−トコフェロール−し−
アスコルビン酸−2−リン酸エステルを含有する比較例
4も、メラニン形成抑制効果、皮膚色明度回復効果は不
十分であり、実用試験の結果も良くなかった。α-tocopherol as an ascorbic acid derivative
Comparative Example 4 containing ascorbic acid-2-phosphate ester also had insufficient melanin formation inhibiting effect and skin color brightness recovery effect, and the results of practical tests were also poor.
それに比べてアスコルビン酸誘導体として、般式(1)
〜(rV)で表されるアスコルビン酸誘導体を含有する
実施例1〜8は、高いチロンナーゼ活性阻害率を有し、
しかも保存安定性が良好で、メラニン形成抑制効果及び
皮膚色明度回復効果に優れており、しかも実用試験の結
果も良かった。In comparison, as an ascorbic acid derivative, the general formula (1)
Examples 1 to 8 containing ascorbic acid derivatives represented by ~(rV) have a high thyronase activity inhibition rate,
Moreover, it has good storage stability, excellent melanin formation inhibiting effect and skin color brightness recovery effect, and also had good results in practical tests.
実施例9〜16.比較例5〜8
(スキンクリーム)
実施例]と同様に、下記の組成に於いて種々の実施例、
比較例のスキンクリームを調製して諸試(2) 調製
方法
(A)成分の内、油溶性のものは(B)成分中に、また
水溶性のものは(C)成分中に混合し、(B)成分と(
C)成分を各々均一に加p 熔解して温度を80℃にす
る。次いで、(B)成分中に(C)成分を注入撹拌rR
合した後、
撹拌しながら温度を3
℃
(3) 特性
第4表に示す如く、比較例5〜8G二対して本発明の美
白化粧料である実施例9〜16:ま詩誌X!cこ於いて
全て良好な結果を示し、美白効果も優ね、ていること;
ま明らかであった。Examples 9-16. Comparative Examples 5 to 8 (Skin Cream) Similarly to [Example], various Examples with the following composition,
Preparation of skin cream of comparative example and various tests (2) Preparation method Among the components (A), oil-soluble ones are mixed in the (B) component, water-soluble ones are mixed in the (C) component, (B) Ingredients and (
C) Uniformly add and melt each component and bring the temperature to 80°C. Next, inject (C) component into (B) component and stir rR.
After mixing, the temperature was raised to 3°C while stirring. It shows good results in all cases and has an excellent whitening effect;
Well, it was obvious.
実施例17〜24.比較例9〜12
(乳液)
実施例1と同様に、下記の組成乙こ於し1て種々の実施
例、比較例の乳液を調製して本試験を実施した。その結
果を第5表に示じた。Examples 17-24. Comparative Examples 9 to 12 (Emulsions) In the same manner as in Example 1, emulsions of various Examples and Comparative Examples were prepared with the following compositions and the present test was carried out. The results are shown in Table 5.
組成
(2′自 調製方法
(A)成分の内、油溶性のものは(B)成分中に、また
水溶性のものは(C)成分中6:混合し、(B)成分と
(C)成分を各々均一に加熱溶解して温度を80°Cに
する。次いで、(B)成分中乙こ(C)成分を圧入撹拌
混合した後、
撹拌しながら温度を3
℃
f31 特性
第5表に示す如く、比較例9〜12に対して本発明の美
白化粧料である実施例17〜24は、詩誌験に於いて全
て良好な結果を示し、美白効果も優れていることは明ら
かであった。Composition (2' Self-preparation method) Of the components (A), the oil-soluble ones are in the (B) component, and the water-soluble ones are in the (C) component. Each component is heated and dissolved uniformly to bring the temperature to 80°C.Next, the (B) component and (C) component are mixed by pressure, and the temperature is increased to 3°C while stirring. As shown, in contrast to Comparative Examples 9 to 12, Examples 17 to 24, which are whitening cosmetics of the present invention, all showed good results in the poetry test, and it is clear that they have excellent whitening effects. Ta.
(発明の効果〕
以上記載の如く、本発明の美白化粧料は、従来のし一ア
スコルビン酸誘導体を含有する美白化粧料と比較して、
美白効果および保存安定性において顕著に優れているこ
とは明らかである。(Effects of the Invention) As described above, the whitening cosmetic of the present invention has the following effects compared to the conventional whitening cosmetic containing an ascorbic acid derivative:
It is clear that it is significantly superior in whitening effect and storage stability.
Claims (1)
ェロール−L−アスコルビン酸−ジカルボン酸ジエステ
ルを含有することを特徴とする美白化粧料。 ▲数式、化学式、表等があります▼・・・( I ) ▲数式、化学式、表等があります▼・・・(II) (式( I )、(II)中R_1、R_2は、 ▲数式、化学式、表等があります▼ R_3は、CH_2、O、CO、((CH_2)_p−
CH=CH)_q、CHNH_2、((CH_2)_r
−(CHCH_3)_s)_t、((CH_2)_u−
CHOH)_vのいずれかを意味し、x、yは0〜10
の整数、p、q、r、s、t、u、vは0〜4の整数を
表し、R_4、R_5は、H又はCH_3を表す。)(
2)下記一般式(III)又は(IV)で表されるトコフェ
ロール−5,6−O−イソプロピリデン−L−アスコル
ビン酸−ジカルボン酸ジエステルを含有することを特徴
とする美白化粧料。 ▲数式、化学式、表等があります▼・・・(III) ▲数式、化学式、表等があります▼・・・(IV) (但し、R_1、R_2は、( I )、(II)の場合と
同じである。)(1) A whitening cosmetic characterized by containing tocopherol-L-ascorbic acid-dicarboxylic acid diester represented by the following general formula (I) or (II). ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(II) (R_1 and R_2 in formulas (I) and (II) are ▲Mathematical formulas, There are chemical formulas, tables, etc. ▼ R_3 is CH_2, O, CO, ((CH_2)_p-
CH=CH)_q, CHNH_2, ((CH_2)_r
-(CHCH_3)_s)_t, ((CH_2)_u-
CHOH)_v, x and y are 0 to 10
The integers p, q, r, s, t, u, and v represent integers of 0 to 4, and R_4 and R_5 represent H or CH_3. )(
2) A whitening cosmetic containing tocopherol-5,6-O-isopropylidene-L-ascorbic acid-dicarboxylic acid diester represented by the following general formula (III) or (IV). ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(III) ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(IV) (However, R_1 and R_2 are the same as in the case of (I) and (II). are the same)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27132990A JPH04149113A (en) | 1990-10-08 | 1990-10-08 | Whitening cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27132990A JPH04149113A (en) | 1990-10-08 | 1990-10-08 | Whitening cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04149113A true JPH04149113A (en) | 1992-05-22 |
Family
ID=17498537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27132990A Pending JPH04149113A (en) | 1990-10-08 | 1990-10-08 | Whitening cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04149113A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001004114A1 (en) * | 1999-07-08 | 2001-01-18 | Senju Pharmaceutical Co., Ltd. | Diesters of maleic or fumaric acid |
US6828348B2 (en) | 2001-06-06 | 2004-12-07 | Senju Pharmaceutical Co., Ltd. | L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
US8865228B2 (en) | 2006-02-21 | 2014-10-21 | Mary Kay Inc. | Stable vitamin C compositions |
EP3092220A4 (en) * | 2013-09-25 | 2017-08-30 | University of Florida Research Foundation, Inc. | Vitamin c prodrugs and uses thereof |
-
1990
- 1990-10-08 JP JP27132990A patent/JPH04149113A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001004114A1 (en) * | 1999-07-08 | 2001-01-18 | Senju Pharmaceutical Co., Ltd. | Diesters of maleic or fumaric acid |
US6828348B2 (en) | 2001-06-06 | 2004-12-07 | Senju Pharmaceutical Co., Ltd. | L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
US8865228B2 (en) | 2006-02-21 | 2014-10-21 | Mary Kay Inc. | Stable vitamin C compositions |
US9968539B2 (en) | 2006-02-21 | 2018-05-15 | Mary Kay Inc. | Stable vitamin C compositions |
US10912729B2 (en) | 2006-02-21 | 2021-02-09 | Mary Kay Inc. | Stable vitamin c compositions |
US11771638B2 (en) | 2006-02-21 | 2023-10-03 | Mary Kay Inc. | Stable vitamin C compositions |
EP3092220A4 (en) * | 2013-09-25 | 2017-08-30 | University of Florida Research Foundation, Inc. | Vitamin c prodrugs and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4002532C2 (en) | ||
JPS5857307A (en) | Cosmetic | |
JP2903412B2 (en) | Cosmetics | |
JPH0751491B2 (en) | Emulsified cosmetics containing crude drugs | |
JPH04149113A (en) | Whitening cosmetic | |
JP2684615B2 (en) | Skin cosmetics | |
JPH0418010A (en) | W/o/w type emulsified cosmetic | |
JPH03153609A (en) | Skin-beautifying cosmetic | |
JP3460100B2 (en) | Whitening agent | |
JPS61207312A (en) | Skin-beautifying cosmetic | |
JP2663136B2 (en) | Whitening cosmetics | |
JPH04149115A (en) | Whitening cosmetic | |
JPH04149117A (en) | Skin-beautifying cosmetic | |
JP2906269B2 (en) | External preparation for skin | |
JP2719273B2 (en) | Skin cosmetics | |
JPH04149114A (en) | Whitening cosmetic | |
JP3517068B2 (en) | Skin cosmetics | |
JPS6245510A (en) | Skin-beautifying cosmetic | |
JP2753639B2 (en) | Cosmetics | |
JP2744485B2 (en) | Whitening cosmetics | |
JPH09118613A (en) | Skin cosmetic | |
JPH0114202B2 (en) | ||
JPH05331020A (en) | Skin cosmetic | |
JPS58164504A (en) | Anti-suntan cosmetic | |
JPH05345714A (en) | Skin cosmetic |